Abstract
In this case series, we describe our successful use of a reduced hirudin dosage as an anticoagulant during cardiac surgery using minimized extracorporeal circulation in patients with heparin-induced thrombocytopenia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have